PeptiDream Inc (PPTDF)
13.11
0.00 (0.00%)
USD |
OTCM |
May 02, 16:00
PeptiDream Cash from Investing (Quarterly): -3.046M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.046M |
| September 30, 2023 | 18.14M |
| June 30, 2023 | -2.930M |
| March 31, 2023 | -2.882M |
| December 31, 2022 | -14.76M |
| September 30, 2022 | 10.72M |
| June 30, 2022 | -1.523M |
| March 31, 2022 | -204.38M |
| December 31, 2021 | -5.344M |
| September 30, 2021 | -11.35M |
| June 30, 2021 | -0.1871M |
| March 31, 2021 | -3.927M |
| December 31, 2020 | -4.159M |
| September 30, 2020 | -0.3424M |
| June 30, 2020 | -4.290M |
| March 31, 2020 | -2.451M |
| September 30, 2019 | -0.0869M |
| June 30, 2019 | 1.043M |
| March 31, 2019 | 0.5822M |
| December 31, 2018 | -11.04M |
| September 30, 2018 | -1.922M |
| Date | Value |
|---|---|
| June 30, 2018 | -15.10M |
| March 31, 2018 | -1.812M |
| December 31, 2017 | -0.0405M |
| September 30, 2017 | -21.56M |
| June 30, 2017 | -1.343M |
| March 31, 2017 | -0.5272M |
| December 31, 2016 | -15.65M |
| September 30, 2016 | -0.2887M |
| June 30, 2016 | -15.09M |
| March 31, 2016 | -0.8759M |
| December 31, 2015 | 9.785M |
| September 30, 2015 | -2.249M |
| June 30, 2015 | -8.252M |
| March 31, 2015 | 7.054M |
| December 31, 2014 | 8.907M |
| September 30, 2014 | 0.7159M |
| June 30, 2014 | -1.047M |
| March 31, 2014 | -1.415M |
| December 31, 2013 | -31.88M |
| September 30, 2013 | -0.0342M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-204.38M
Minimum
Mar 2022
18.14M
Maximum
Sep 2023
-12.88M
Average
-2.906M
Median
Cash from Investing (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | -460.58M |
| Nxera Pharma Co Ltd | -18.93M |
| Stemcell Holdings Inc | -0.1868M |
| Healios KK | -0.8731M |
| AnGes Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 24.93M |
| Cash from Financing (Quarterly) | 22.30M |
| Free Cash Flow | 78.77M |
| Free Cash Flow Per Share (Quarterly) | 0.1641 |
| Free Cash Flow to Equity (Quarterly) | -9.716M |
| Free Cash Flow to Firm (Quarterly) | 22.76M |
| Free Cash Flow Yield | 4.63% |